17:44
2026-05-31
bigpharmasharma.com
ai-startups
Last Week Tonight in BioPharma: Week of May 25th, 2026
Eli Lilly reported positive interim Phase 1b data for its in vivo PCSK9 base editor VERVE-102, showing single-dose LDL-C reductions of up to 62% sustained for 18 months in patients with heterozygous f…